However, to our knowledge, there is a dearth of research exploring whether the effect of Lp(a) on adverse prognosis would be simultaneously modified by LDL‐C and hs‐CRP levels in CAD patients. The gene discussed is MAP3K14; the disease is coronary artery disorder.